Description
CJC-1295 with DAC incorporates a Drug Affinity Complex (DAC) that enables covalent binding to serum albumin, significantly extending the half-life compared to the non-DAC formulation. This long-acting GHRH analog is studied in research models requiring sustained receptor activation rather than pulsatile GH stimulation.
This 2mg vial is HPLC and MS/MS validated to 99%+ purity. COA provided.
For research use only. Not for human or veterinary consumption.




